FDA to Examine Asbestos Testing for Talc Powders at Tuesday Hearing
The U.S. Food and Drug Administration (FDA) will examine asbestos testing for talcum powders and cosmetics at a Tuesday hearing.
Regulators are closely reviewing after finding asbestos, a known carcinogen, in several talc cosmetics and powders, along with a bottle of Johnson & Johnson’s well-recognized Baby Powder. Citing those FDA outcomes, some U.S. legislators and client advocates have known as stricter safety laws to protect public health.
J&J, the market leader in talc powders, has defended the safety of its talc. The company stated tests by labs it selected found no asbestos in samples from the same bottle the FDA reviewed – except for some the company attributed to contamination from a lab air conditioner.
In a press release, the corporate stated it seems to be forward to the FDA’s “thorough review of the simplest and reliable methods to test for asbestos in cosmetic talc.”
The hearing on asbestos testing in talc, the FDA’s first since 1971, will focus on testing standards suggested by a panel of government specialists. The suggestions, revealed last month, include positions held by public health authorities and experts for plaintiffs who allege that contaminated talc products caused their cancers.
After listening to from the government committee, FDA officers will take public comment from shopper advocates, industry representatives, and testing experts.
For many years, the cosmetic talc industry has mostly been allowed to police itself with little oversight from the FDA. Although talc and asbestos are similar minerals often discovered collectively in the ground, the FDA has never compelled companies to check for the carcinogen.